PRP(27-30) is a normal soluble prion protein fragment released by human platelets

被引:70
作者
Perini, F
Vidal, R
Ghetti, B
Tagliavini, F
Frangione, B
Prelli, F
机构
[1] NYU, MED CTR, DEPT PATHOL, NEW YORK, NY 10016 USA
[2] NYU, MED CTR, DEPT NEUROL, NEW YORK, NY 10016 USA
[3] INDIANA UNIV, SCH MED, DEPT PATHOL, INDIANAPOLIS, IN 46202 USA
[4] IST NEUROL CARLO BESTA, I-20133 MILAN, ITALY
关键词
D O I
10.1006/bbrc.1996.0936
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prion diseases are neurodegenerative disorders characterized by the accumulation of abnormal isoforms of prion protein (PrPSc) in the central nervous system. PrPSc isoforms differ from their normal homologue (PrPC), in that they possess increased beta-sheet conformation, are partially protease resistant and may be associated with amyloid deposition. Amyloid proteins are thought to derive from soluble precursors or fragments thereof, present in biological fluids, which in the disease state undergo conformational change leading to aggregation and deposition in target tissues. We report here that platelets carry PrP mRNA and release PrPC, a sialoglycoprotein bound to the cell surface by a glycosylphosphatidylinositol (GPI) anchor. Soluble PrPC and a N-terminal truncated PrPC isoform starting at position 90 are secreted by resting and agonist-stimulated platelets and are detectable after partial deglycosylation of releasates. N-terminal sequence analysis of the soluble 27-30 kDa isoform. GQGGGTHSQ(W)NKP, revealed homology to scrapie PrP27-30, the protease resistant core derived from PrPSc. These findings indicate that in addition to PrPC, platelets process a soluble PrP27-30 isoform. Whether this isoform can be converted into scrapie PrP27-30 remains to be determined. (C) 1996 Academic Press, Inc.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 32 条
[1]   PRION PROTEIN ISOFORMS, A CONVERGENCE OF BIOLOGICAL AND STRUCTURAL INVESTIGATIONS [J].
BALDWIN, MA ;
COHEN, FE ;
PRUSINER, SB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (33) :19197-19200
[2]   NEARLY UBIQUITOUS TISSUE DISTRIBUTION OF THE SCRAPIE AGENT PRECURSOR PROTEIN [J].
BENDHEIM, PE ;
BROWN, HR ;
RUDELLI, RD ;
SCALA, LJ ;
GOLLER, NL ;
WEN, GY ;
KASCSAK, RJ ;
CASHMAN, NR ;
BOLTON, DC .
NEUROLOGY, 1992, 42 (01) :149-156
[3]   THE MESSENGER-RNA ENCODING THE SCRAPIE AGENT PROTEIN IS PRESENT IN A VARIETY OF NONNEURONAL CELLS [J].
BROWN, HR ;
GOLLER, NL ;
RUDELLI, RD ;
MERZ, GS ;
WOLFE, GC ;
WISNIEWSKI, HM ;
ROBAKIS, NK .
ACTA NEUROPATHOLOGICA, 1990, 80 (01) :1-6
[4]  
BURKEY BF, 1991, J LIPID RES, V32, P1039
[5]   NON-ALZHEIMERS DISEASE AMYLOIDOSES OF THE NERVOUS-SYSTEM [J].
CASTANO, EM ;
FRANGIONE, B .
CURRENT OPINION IN NEUROLOGY, 1995, 8 (04) :279-285
[6]   PRION PROTEIN-BIOSYNTHESIS IN SCRAPIE-INFECTED AND UNINFECTED NEURO-BLASTOMA CELLS [J].
CAUGHEY, B ;
RACE, RE ;
ERNST, D ;
BUCHMEIER, MJ ;
CHESEBRO, B .
JOURNAL OF VIROLOGY, 1989, 63 (01) :175-181
[7]   TRUNCATED FORMS OF THE HUMAN PRION PROTEIN IN NORMAL BRAIN AND IN PRION DISEASES [J].
CHEN, SG ;
TEPLOW, DB ;
PARCHI, P ;
TELLER, JK ;
GAMBETTI, P ;
AUTILIOGAMBETTI, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19173-19180
[8]   MOLECULAR-GENETICS OF HUMAN PRION DISEASES [J].
COLLINGE, J ;
PALMER, MS .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1994, 343 (1306) :371-378
[9]   PRION PROTEIN IS NECESSARY FOR NORMAL SYNAPTIC FUNCTION [J].
COLLINGE, J ;
WHITTINGTON, MA ;
SIDLE, KCL ;
SMITH, CJ ;
PALMER, MS ;
CLARKE, AR ;
JEFFERYS, JGR .
NATURE, 1994, 370 (6487) :295-297
[10]   PLATELET MODELS AND THEIR POSSIBLE USEFULNESS IN THE STUDY OF MIGRAINE PATHOGENESIS [J].
DANDREA, G ;
CANANZI, AR ;
PERINI, F ;
HASSELMARK, L .
CEPHALALGIA, 1995, 15 (04) :265-271